Epidemiology And Risk Factors Of Intradialytic Hypotension In Maintenance Hemodialysis Patients

This is a prospective, multicenter, observational study designed to characterize the epidemiology and risk factors of intradialytic hypotension (IDH) in adult patients undergoing maintenance hemodialysis. No study-specific interventions will be assigned; all dialysis treatments and medical therapies will be conducted according to routine clinical practice at each participating center. Eligible participants are adults receiving thrice-weekly or regular maintenance hemodialysis for end-stage kidney disease. After obtaining informed consent (as required by local regulations), baseline data will be collected from the medical record and patient interview. Baseline variables will include: Demographics (age, sex, body mass index, smoking status) Primary kidney disease and dialysis vintage Comorbidities (e.g., diabetes mellitus, hypertension, cardiovascular disease, heart failure, arrhythmia) Usual medications, with a focus on antihypertensive agents, diuretics, and cardiovascular drugs Pre-dialysis clinical parameters (weight, dry weight, interdialytic weight gain, pre-dialysis blood pressure) Routine laboratory values (e.g., hemoglobin, albumin, electrolytes, calcium-phosphate metabolism indices, markers of inflammation and nutrition, as available) Dialysis prescription and treatment-related parameters will be documented, including dialyzer type, blood flow rate, dialysate flow, dialysate composition (sodium, calcium, bicarbonate), treatment duration, and planned and achieved ultrafiltration volume and ultrafiltration rate. During the observation period (covering a predefined number of consecutive dialysis sessions per patient), blood pressure will be monitored according to local standard practice (for example, before dialysis, at regular intervals during dialysis, and at the end of treatment). Episodes of intradialytic hypotension will be identified using a pre-specified definition (e.g., absolute blood pressure thresholds and/or drop from baseline, with or without associated symptoms), which will be applied consistently across all centers. When feasible, associated symptoms (such as dizziness, cramps, chest discomfort, nausea) and interventions (e.g., reduction or cessation of ultrafiltration, saline infusion, change in dialysate temperature, adjustment of position, or early termination of dialysis) will be recorded. The primary analyses will describe: The incidence and prevalence of intradialytic hypotension in this maintenance hemodialysis population The distribution of IDH episodes by dialysis session phase (early, middle, late), severity, and need for intervention Secondary analyses will evaluate potential risk factors for IDH. These may include: Baseline patient characteristics (age, sex, body mass index, primary disease, comorbidities) Indicators of cardiovascular function and volume status (pre-dialysis blood pressure, interdialytic weight gain, dry weight assessment) Laboratory parameters reflecting anemia, nutritional status, mineral metabolism, and inflammation Dialysis-related factors (treatment time, ultrafiltration volume and rate, dialysate sodium and temperature, antihypertensive medications taken before dialysis) Multivariable regression models or other appropriate statistical methods will be used to examine associations between candidate risk factors and the occurrence of IDH, while adjusting for potential confounders. Subgroup or sensitivity analyses may be performed according to age groups, presence of diabetes or cardiovascular disease, or different ultrafiltration rate categories, depending on sample size and data completeness. This study is not intended to test a specific therapeutic intervention but to provide a comprehensive, real-world description of intradialytic hypotension and its determinants in maintenance hemodialysis patients across multiple centers. The results may support the development of risk stratification tools and guide future interventional studies aimed at preventing or mitigating intradialytic hypotension.